Data de publicação: 15/04/2021 - 09:44
The Conference On Expanding Africa’s Vaccine, organized by the African Union and the Centers for Disease Control in Africa (CDC Africa), held on 12 and 13/4, had the Oswaldo Cruz Foundation (Fiocruz) president as one of the speakers on Tuesday. During Session 8, on the Partnership with Foundations for Vaccine Production, Nísia reaffirmed Fiocruz's commitment to a South-South agenda to support the needs of the African continent...
Notícias
Data de publicação: 14/04/2021 - 18:22
Many viruses can hamper coagulation, including those that cause dengue fever and yellow fever. In more severe cases, they may lead to bleeding. This is why these diseases are considered hemorrhagic viral fevers. In a paper recently published in the science magazine “Memórias do Instituto Oswaldo Cruz”, a group of ten researchers argues that the new coronavirus (SARS-CoV-2) should be the first agent recognized as acting in the...
Notícias
Data de publicação: 12/04/2021 - 18:06
After 6 years of the epidemic that put Northeast Brazil in its epicenter, the Zika virus and its consequences may be away from the spotlight, but it is still a burden that needs to be addressed. From March 15th to18th, researchers from the four corners of the world who participated in one of the greatest Zika research consortiums gathered virtually (due to the current pandemic) to discuss its results and ways forward. The event marked the...
Notícias
Data de publicação: 12/04/2021 - 12:42
A methodology that aims to make the monitoring of the new coronavirus variants simpler and faster, besides being cheaper, has just been developed at Fiocruz Pernambuco. It is based on a technique that is already widely used and available in Brazil and in the world, the Sanger sequencing - also called sequencing by capillary electrophoresis. The article with this finding has just been made available online as a preprint on the MedRxiv platform....
Notícias
Data de publicação: 09/04/2021 - 11:04
On April 14, the Oswaldo Cruz Foundation will hold the first PrInt Fiocruz-Capes virtual seminar in 2021. The event is part of a series of integrated seminars between researchers from Fiocruz and Germany, with a diverse thematic.On April 14, the Oswaldo Cruz Foundation will hold the first PrInt Fiocruz-Capes virtual seminar in 2021. The event is part of a series of integrated seminars between researchers from Fiocruz and Germany, with a diverse...
Documento/Arquivo
Data de publicação: 09/04/2021 - 10:17
On April 14, the Oswaldo Cruz Foundation will hold the first PrInt Fiocruz-Capes virtual seminar in 2021. The event is part of a series of integrated seminars between researchers from Fiocruz and Germany, with a diverse thematic. The meeting will be held from 9 am to 11:30 am (Brasilia Time), with transmission through the Fiocruz channel on YouTube.
The seminar, which is aimed at Fiocruz students, seeks to stimulate interest in scientific...
Notícias
Data de publicação: 09/04/2021 - 09:08
A paper to be published in May in the U.S. Centers for Disease Control and Prevention's (CDC/US) journal Emerging Infectious Diseases (EID) shows that a first exposure to COVID-19 in mild or asymptomatic cases may not produce an immune response, and that a person can reinfect himself or herself with the same variant. The second infection can cause stronger symptoms than the first, the study indicates.
(Photo:Isabela Carrari -...
Notícias
Data de publicação: 06/04/2021 - 09:24
With the start of Oxford/AstraZeneca-Fiocruz production vaccine on national territory, and the batches delivery to the Ministry of Health, this stage is beginning to give its first results to Brazilian society. Still this year, the country will have a vaccine produced entirely in Brazil and already in this first semester the manufacture of the first batches of the active pharmaceutical ingredient (API) will start, which should be available to...
Notícias
Data de publicação: 01/04/2021 - 10:02
The Bulletin of the Fiocruz Covid-19 Observatory, released on March 26, shows that the country is facing the collapse of the health system. At the same time, the pandemic is now taking up new shapes, affecting younger age groups: 30 to 39 years old, 40 to 49, and 50 to 59. In such a scenario, researchers defend the adoption of measures in two interconnected groups.
The first group includes urgent measures that involve the containment of the...
Notícias
Data de publicação: 30/03/2021 - 17:26
This March 2021, the Pan American Health Organization/World Health Organization (PAHO/WHO) designated the National Institute for Women's, Children's and Adolescent Health Fernandes Figueira (IFF/Fiocruz) as a PAHO/WHO Collaborating Center to strengthen Human Milk Banks. The designation as a Collaborating Center will be valid for a four years period, starting on March 3, 2021, and can be renewed by redesignation.
The designation as...
Notícias
Data de publicação: 30/03/2021 - 17:10
Executive:
Viviane Santos de Oliveira Veiga
Fundação Oswaldo Cruz (FIOCRUZ)
Maria Luiza Machado Campos
Universidade Federal do Rio de Janeiro (UFRJ)
João Luiz Rebelo Moreira
University of Twente (International Representative)
Patricia Corrêa Henning
Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Luiz Olavo Bonino da Silva Santos
VODAN IN consultant
Researchers:
Sergio...
Páginas Institucionais (antigas)
Data de publicação: 30/03/2021 - 17:01
Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Carlos Roberto Lyra da Silva - Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Gaffree Guinle Hospital
Romero de Melo Silva - Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Sérgio Luis Teixeira de Aquino - Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Jorge da Cunha Barbosa Leite - Universidade Federal do Estado do Rio de...
Páginas Institucionais (antigas)
Data de publicação: 30/03/2021 - 16:47
The VODAN Brazil Implementation Network was established through the efforts of teams from the Oswaldo Cruz Foundation (Fiocruz), Federal University of Rio de Janeiro (UFRJ), Federal University of the State of Rio de Janeiro (UNIRIO) and São José Municipal Hospital. The Vodan Brazil aims to provide an infrastructure capable of enabling health units to collect and manage medical data of patients infected with COVID-19....
Páginas Institucionais (antigas)
Data de publicação: 26/03/2021 - 14:14
Autoras: Gabriela Lotta, Michelle Fernandez, Denise Pimenta, Clare Wenham.
Publicação original em inglês.
Confira mais informações no Observatório Covid-19.
Acesse o especial da Fiocruz sobre a Covid-19.
Documento/Arquivo
Data de publicação: 26/03/2021 - 12:51
Scientists at the Fiocruz Genomics Network have identified important changes in the Spike (S) protein structure of the Sars-CoV-2 virus circulating in Brazil. Eleven gene sequences showed deletions (loss of genetic material) in the initial region of the protein and in four there was some amino acids insertion. The Spike protein is associated with the pathogen's ability to enter human cells and is one of the main targets of the neutralizing...
Notícias
Data de publicação: 26/03/2021 - 11:50
Science formulated with collaboration and transparency. On March 17th, the Oswaldo Cruz Foundation (Fiocruz) presented the advances in the implantation of the Institutional Data Repository for Research - Arca Dados, an important element to implement the Policy for Management, Sharing and Opening of Data for Research. The document (approved in September 2020 by the Deliberative Council of Fiocruz and whose Ordinance came into term in December) is...
Notícias
Data de publicação: 18/03/2021 - 13:30
The United Kingdom ambassador in Brazil, Peter Wilson, visited the Oswaldo Cruz Foundation (Fiocruz) on March 5 for a meeting with the president of the institution, Nísia Trindade Lima, and to visit the Immunobiological Technology Institute (Bio-Manguinhos) plant that is producing the Covid-19 Fiocruz vaccine.
Photo: Pedro Paulo Gonçalves
“I greatly admire the work you have you been doing, and we are here to know...
Notícias
Data de publicação: 18/03/2021 - 11:31
Edgar Marcelino de Carvalho, a researcher of Fiocruz Bahia, was considered the world’s greatest specialist in cutaneous leishmaniasis by the site Expertscape. The ranking was based on science publications: Carvalho published 84 papers on the subject between 2010 and 2021. The ranking includes the 66 scientists with most papers published on cutaneous leishmaniasis from all over the world and also includes three other researchers of Fiocruz...
Notícias
Data de publicação: 18/03/2021 - 10:39
Six years after the National Health Emergency declared by the Brazilian Ministry of Health, Zika is still a public health issue that mobilizes many actors in society. Fiocruz is launching the virtual exhibition Zika: lives affecting lives, produced by the Zika Social Sciences Network and the Oswaldo Cruz House (COC/Fiocruz), through the Museum of Life. The exhibition is the result of collaborative scientific research, produced with intense...
Notícias
Data de publicação: 17/03/2021 - 09:46
Faced with the current pandemic scenario, Fiocruz released this Tuesday (March 16), another edition of the Fiocruz COVID-19 Observatory Extraordinary Bulletin. The analysis draws attention to the indicators that point to an extremely critical situation across the country. In the view of the researchers who carry it out, this is the biggest health system collapse in the history of Brazil.
The Bulletin shows that, at the moment, of the...
Notícias
Data de publicação: 15/03/2021 - 14:20
On March 11, one year since the World Health Organization (WHO) declared that the COVID-19 epidemic represented a global pandemic, the new Bulletin of the COVID-19 Observatory Fiocruz highlights that Brazil is among the countries with the worst indicators. The country totals 11,122,429 cases and 268,370 deaths, which corresponds to 9.5% and 10.3% of the global total, respectively, even though the Brazilian population is less than 3% of the world...
Notícias
Data de publicação: 15/03/2021 - 11:54
The Brazilian Health Regulatory Agency (Anvisa) granted the definitive registration of the COVID-19 Fiocruz vaccine on March 12. Thus, Fiocruz becomes the first holder of a registration of a COVID -19 vaccine produced in the country and adds to its product portfolio the eleventh vaccine to be supplied to the National Immunization Program (PNI). With the registration, the expectation is that Anvisa will authorize the release of the...
Notícias
Data de publicação: 12/03/2021 - 11:49
In an extraordinary edition of its Bulletin, the Covid-19 Fiocruz Observatory publishes an updated of the historical series on the occupation of COVID-19 ICU beds for adults in the Brazilian Health System (SUS, in the Portuguese acronym), with data obtained on Monday (8/3). The analysis presents rates verified since July 17th, 2020, and aims to alert to the critical scenario of the country. Check out the full document (in Portuguese)....
Notícias
Data de publicação: 10/03/2021 - 18:21
Fiocruz president, Nísia Trindade Lima, participated in a World Health Organization (WHO) discussion on how investing in research on Covid-19 treatments can increase cooperation at national and international levels, on March 3. The discussion table, named Towards a Shared Research Agenda, included in the debate on how to identify knowledge gaps and research priorities for COVID-19 treatments, to incentivize cooperation and...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
